<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5090218 Figure_1-A</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 1-A</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Whole mount in situ hybridization (WISH) of evi1at 20 (left) and 32 (middle) hpf. evi1expression is visible in various structures of the brain, neuronal structures, the posterior pronephric duct (ppnd) and the branchial arches (ba), as well as in the VDA (ventral dorsal aorta) region. Additionally, evi1co-localizes with the endothelial marker flk1 (right).</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_1-B-H</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 1-B-H</infon>
    <infon key="sourcedata_figure_dir">Figure_1-B-H</infon>
    <passage>
      <offset>0</offset>
      <text>B, C. WISH of runx1/c-myb ;in HSPCs (B), mpo in neutrophils (left) and l-plastin (right) in monocytes/macrophages (C) at 36 hpf in control (upper) and evi1 MO (lower) injected embryos. D-G. WISH of globinin erythrocytes of 6 dpf old embryos (D), of rag-1in the thymus of 5 dpf embryos (E; red asterisk), of cd41at 52 hpf (F), and gata2bat 32 hpf (G) for both control (upper) and evi1 morpholino (lower) injected embryos. H. Quantitation of results is shown for each gene, displaying the percentages of embryos with normal vs. changed expression in each condition. A Fisher&#180;s exact test was applied to calculate statistical significance. P &lt; 0.001 (***).</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_1-I-J-K</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 1-I-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_1-I-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>I. WISH of runx1/c-myb in HSPCs of uninjected control and UAS:mEvi1 plasmid DNA injected Tg(-1.5hsp70l:Gal4) embryos with heat-shock induction performed at 14 hpf. J. WISH of runx1/c-myb in HSPCs of uninjected control and UAS:mEvi1 mRNA in Tg(fli.1:Gal4FF;UAS:RFP) embryos, leading to endothelial-specific evi1 overexpression. K. Graph displays quantitation of results from I and J using the same method as above.</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_2-A</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 2-A</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. WISH of notch1b(upper) and dll4(lower) in both control (left) and evi1 MO injected embryos (right).</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_2-B</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 2-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. WISH of notch1b in uninjected (left) and UAS:mEvi1 plasmid DNA injected (right) Tg(fli.1:Gal4FF;UAS:RFP) embryos resulting in endothelial-specific evi1 induction.</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_3-A-B</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 3-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A. Confocal time-lapse live imaging was performed in Tg(c-myb:GFP;kdrl:mKate-CAAX) embryos from 28 to 42 hpf (Movie EV 1). Shown are three representative time-points in which the transformation from hemogenic endothelial cells to the hematopoietic fate is visible, indicated by the white arrowheads. For each time-point merged images are shown. White arrowheads denote double-positive cells. B. Cell counts of total numbers of kdrl+cmyb1+ cells "in view", dividing and respectively emerging HSPCs. n=10 movies from n=3 biological replicates were analyzed. A non-parametric Mann-Whitney test was used to test for statistical significance and error bars are shown as &#177; s.d.</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_3-C</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>C. Gene expression analysis of endothelial (kdrl, flt1, dab2, cdh5) and blood specific genes (c-myb, CD45, CD41, runx1) in sorted kdrl+c-myb+ cells from 34 hpf Tg(c-myb:GFP;kdrl:mKate-CAAX) embryos. Cells were isolated from 15-25 pooled embryos per sample. Three biological experiments were performed with one representative shown. Error bars indicate s.d.&#8232;of three technical replicates for each representative experiment.</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_4-A-E</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 4-A-E</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-E</infon>
    <passage>
      <offset>0</offset>
      <text>A. WISH for runx1/c-mybin 36 hpf evi1 morphant (left) and evi1 morphant transgenic Tg(5xUAS-E1b:6xMYC-notch1a;-1.5hsp70l:Gal4) embryos (right) with global heat-shock (HS) induction at 20 hpf. B. WISH for runx1/c-myb in 36 hpf evi1 morphant (left) and evi1 morphant transgenic Tg(5xUAS-E1b:6xMYC-notch1a;cdh5:gal4ff) embryos with endothelial-specific NICD induction (right). C. WISH for runx1/c-myb in 36 hpf evi1 morphant (left) and evi1 morphant transgenic Tg(Hsp70l:vegfaa;myl7:eGFP) embryos (right) with global heat-shock induction at 20 hpf. D. WISH for runx1/c-mybin 32 hpf evi1 MO injected embryos (left) and embryos injected with both evi1 MO and capped gata2 mRNA (right). E. Quantitation of all rescue experiments. Shown are the percentages of embryos displaying normal or changed runx1/c-myb expression. A Fisher&#180;s exact test was applied to calculate statistical significance. (n.s., not significant; p &lt; 0.001 (***); p&lt;0.01 (**)).</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_5-A-B</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A. Confocal time-lapse live imaging was performed in Tg(c-myb:GFP;fli.1:UAS;Gal4:RFP) evi1 morphant embryos (top, Movie EV 2) or in Tg(c-myb:GFP;fli.1:UAS;Gal4:RFP) crossed to Tg(5xUAS-E1b:6xMYC-notch1a) embryos prior to MO injection (bottom, Movie EV 3) from 28 to 42 hpf. Shown are three representative time-points, in which the transformation from hemogenic endothelial cells to the hematopoietic fate is visible. For each time-point merged images are shown. NICD induction controlled by endothelial fli.1 (lower panel) can rescue the evi1 morphant phenotype and increases the number of HSPCs cells emerging from the VDA (arrows). B. Cell counts of emerging HSPCs in control and evi1 morphant fish with or without endothelial NICD induction. At least n=5 movies from n=3 biological replicates were analyzed. A non-parametric Mann-Whitney test was used to test for statistical significance and error bars are shown as &#177; s.d. (n.s., not significant, p&lt;0.05 (*)).</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_6-A</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 6-A</infon>
    <infon key="sourcedata_figure_dir">Figure_6-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. WISH of dll4(upper) and notch1b(lower) in control injected embryos (left), evi1 morphants (middle) and evi1 morphant transgenic Tg(Hsp70l:vegfaa;myl7:eGFP) embryos at 32 hpf after heat-shock induction at 20 hpf (right).</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_6-B-C</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 6-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>B, C. WISH of runx1/c-myb(B) or notch1b(C) after treatment with DMSO (left), the VEGF receptor inhibitor SU5461 (middle) and respectively SU5461 after injection of UAS:mEvi1 (inducing endothelial evi1 expression) in Tg(fli.1:Gal4FF;UAS:RFP) embryos (right).</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_7-A</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 7-A</infon>
    <infon key="sourcedata_figure_dir">Figure_7-A</infon>
    <passage>
      <offset>0</offset>
      <text>A. Expression of runx1/c-myb in the VDA after treatment with DMSO vehicle control (left), the PI3K/AKT inhibitor Wortmannin (WM, middle) and after joined treatment with WM and enforced NICD expression via HS at 14 hpf in Tg(5xUAS-E1b:6xMYC-notch1a;-1.5hsp70l:Gal4) embryos (right). Graph displays quantitation of results. Shown are the percentages of embryos with normal or decreased runx1/c-mybexpression for each condition.</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_7-B</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 7-B</infon>
    <infon key="sourcedata_figure_dir">Figure_7-B</infon>
    <passage>
      <offset>0</offset>
      <text>B. Expression of notch1b after treatment with DMSO vehicle control (left) or Wortmannin (WM, middle). Graph displays quantitation of results. Shown are the percentages of embryos with normal or decreased notch1b expression for each condition.</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_7-C-D</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 7-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_7-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C. WISH for runx1/c-myb in control injected embryos (upper left), evi1 morphants (upper right) or respectively evi1 MO with myr-AKT injected embryos with HS at 14 hpf (lower right) and evi1 MO with UAS-myr-AKT injected transgenic Tg(fli.1:Gal4FFubs3; UAS:RFP)rk embryos. D. Quantitation of results from (C). Shown are the percentages of embryos with normal or decreased runx1/c-myb expression for each condition.</text>
    </passage>
  </document>
  <document>
    <id>5090218 Figure_7-E</id>
    <infon key="sourcedata_document">2285</infon>
    <infon key="doi">10.15252/embj.201593454</infon>
    <infon key="pmc_id">5090218</infon>
    <infon key="figure">Figure 7-E</infon>
    <infon key="sourcedata_figure_dir">Figure_7-E</infon>
    <passage>
      <offset>0</offset>
      <text>E. WISH for notch1b in evi1 Morpholino injected (left) and evi1 plus UAS:myr-AKT injected transgenic Tg(fli.1:Gal4FFubs3; UAS:RFP)rk embryos (right). Graph displays quantitation of results. Shown are the percentages of embryos with normal or decreased notch1b expression for each condition.</text>
    </passage>
  </document>
</collection>
